Fox Chase Cancer Center News

Fox Chase Cancer Center Physician Demonstrates Safety and Effectiveness of Myeloma Drug for Black or African American Patients at American Society of Hematology Meeting

PHILADELPHIA (December 11, 2023) — Asya Varshavsky-Yanovsky, MD, PhD, an Assistant Professor in the Department of Bone Marrow Transplant and Cellular Therapies at Fox Chase Cancer Center, has presented an analysis showing that the multiple myeloma drug elranatamab is safe and effective for Black or African American patients with relapsed/refractory multiple myeloma (RRMM).

VIEW STORY

Fox Chase Cancer Center’s Edna “Eti” Cukierman Named to Newly Created Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research

PHILADELPHIA (December 11, 2023) — Edna “Eti” Cukierman, PhD, Co-Leader of the Cancer Signaling and Microenvironment Research Program and Co-Director of The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, has been appointed to the newly created Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research.

VIEW STORY

Researcher at Lewis Katz School of Medicine at Temple University and Fox Chase Co-Authors Study That Explains Why PIM Inhibitors Fall Short in Clinical Trials

PHILADELPHIA (November 29, 2023) — A new study co-authored by a researcher from the Lewis Katz School of Medicine at Temple University and Fox Chase Cancer Center helps explain why drugs targeting a type of enzyme called PIM kinases, which are known to play an important role in several cancers, have largely failed in clinical trials. The findings also indicate that another approach may be significantly more effective.

VIEW STORY

Study Identifies Key Mutations That Make New DNA Repair Enzyme Inhibitors More Effective

PHILADELPHIA (November 28, 2023) — Research into alternative therapies for breast and ovarian cancers that contain BRCA1, PALB2, or BRCA2 mutations has focused on developing new drugs targeting an enzyme that helps repair damaged DNA. But a study published in the prestigious journal Nature Communications by researchers at Fox Chase Cancer Center shows that this approach may be most effective for PALB2 and BRCA2 mutation-containing cancers.

VIEW STORY

Fox Chase’s Dr. Sanjay S. Reddy Appointed to Volunteer Position With the American Board of Surgery and New Position With the Society of Surgical Oncology

PHILADELPHIA (November 28, 2023) — Sanjay S. Reddy, MD, FACS, Co-Director of the Marvin & Concetta Greenberg Pancreatic Institute and an Associate Professor in the Department of Surgical Oncology at Fox Chase Cancer Center, was recently appointed to a volunteer position with the American Board of Surgery and a position with the Society of Surgical Oncology.

VIEW STORY